RP۱۳۹۷/۸/۲۰ ،۱۶:۰۸:۵۳ +۰۰:۰۰

 

در این بخش مطالب مرتبط با بیماری آرپی- آخرین  مقالات و روند درمانهای نوین قرار میگیرد

Blue light from smart phones and digital devices could raise risk of blindness


Scientists reverse congenital blindness in mouse model


Scientists report novel gene therapy that halts vision loss in canine model of blinding disease


ProQR In-licenses Worldwide Rights to Ophthalmology Drug Candidate from Ionis Pharmaceuticals


Understanding Retinitis Pigmentosa


Assessment of the Electronic Retinal Implant Alpha AMS in Restoring Vision to Blind Patients with End-Stage Retinitis Pigmentosa


Open PDF


Visual Acuity Change Over 24 Months and its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease


Gene Therapy for Blindness


Companion animals: Translational scientist’s new best friends


X linked retinoschisis


Rab escort protein 1 (REP1) in intracellular traffic: a functional and pathophysiological overview


PROGRESS IN RETINAL AND EYE RESEARCH 2003


Ophthalmic features of Friedreich ataxia


Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial


The retina translates light into a language the brain understands


Bilateral Symmetry of Visual Function Loss in Cone–Rod Dystrophies


Characterization of Visual Function, Interocular Variability and Progression Using Static Perimetry–Derived Metrics in RPGR-Associated Retinopathy


The Key to Commercializing Revolutionary Gene Therapies and Other Orphan Drugs: High-Touch Services that Enhance Patient Outcomes


Development of a Chromatic Pupillography Protocol for the First Gene Therapy Trial in Patients With CNGA3- Linked Achromatopsia


Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial


How to use the ICF


Eye movement training is most effective when it involves a task-relevant sensorimotor decision


Inherited Retinal Degenerations: Current Landscape and Knowledge Gaps


G-substrate and Phosphatase Activation in Retinitis Pigmentosa


Methodological Insights for Randomized Clinical Trials of Retinitis Pigmentosa Lessons Learned From a Trial of Valproic Acid


Virally delivered Channelrhodopsin-2 Safely and Effectively Restores Visual Function in Multiple Mouse Models of Blindness


Olfactory Dysfunction in Patients With CNGB1-Associated Retinitis Pigmentosa


UPDATE ON RESEARCH FOR RP TREATMENT: VITAMIN A PALMITATE, OMEGA-3-RICH FISH AND LUTEIN


Visual Search Behavior in Individuals With Retinitis Pigmentosa During Level Walking and Obstacle Crossing


http://iran-rp.ir/wp-content/uploads/2018/09/uk-XLRS.pdf


Tunnel Vision Prismatic Field Expansion: Challenges and Requirements


Treating the Eyes to Help the Brain


Toward the Mutational Landscape of Autosomal Dominant Retinitis Pigmentosa: A Comprehensive Analysis of 258 Spanish Families


The Spectrumof Structural and Functional Abnormalities in Female Carriers of Pathogenic Variants in the RPGR Gene


The Economic Impact of Blindness in Europe


Significant Relationship of Visual Field Sensitivity in Central 108 to Thickness of Retinal Layers in Retinitis Pigmentosa


Risk Factors for Posterior Subcapsular Cataract in Retinitis Pigmentosa


HORAMA announces initiation of a Phase I/II Clinical Study for HORA-PDE6B, in Retinitis Pigmentosa (RP)